Merganser Biotech, Inc. Company Profile
Merganser Biotech is a largely virtual, development only company focused on the licensing and development of early stage, novel peptidyl therapeutic approaches to the treatment of human diseases. Its lead project is the development of hepcidin mimetic peptides for the treatment of iron overload in diseases such as beta thalassemia and hemochromatosis. Led by experienced biopharmaceutical executives and having received funding from BioAdvance and angel investors, Merganser intends to advance this program into clinical development.
News Articles
Hip to hep: Sidebar: Merganser Biotech Inc.
Merganser: Hip to hep Merganser Biotech Inc. Newtown Square, Pa. Technology: Peptide mimetics of the iron regulatory hormone hepcidin Disease focus: Hematology Clinical status: Preclinical Founded: 20...
Merganser is looking to tackle beta thalassemia using hepcidin peptides that can reduce the toxic accumulation of iron rather than mopping it up after the fact as marketed chelators do.
The Entrepreneurial Diaspora Enabled By Biotech M&A
The recycling of equity capital through realized returns is a critically important element of biotech investing. When public biotech companies get bought, like Genentech by Roche, or smaller deals l...
Biotech crops gaining worldwide acceptance
For the first time since the introduction of biotech crops almost two decades ago, developing countries grew biotech crops on more land than in industrialized countries in 2012, according to a report...
Agila Biotech to Set Up Biotech Facility at Malaysia's Bio-XCell Ecosystem
Agila Biotech aims for the R&D and manufacturing facilities to be operational by end-2014.
Ãœbernahme von BB Biotech abgesagt
Die Biotech-Beteiligungsgesellschaft BB Biotech bleibt eigenständig. Ein Übernahmeversuch der...
More Farmers Around the World Plant Biotech Crops
ISAAA (International Service for the Acquisition of Agri-Biotech Applications) released their annual report last week on the Global Status of Commercialized Biotech/GM Crops: 2012, showing a record 17...
How To Build a Biotech Cluster That Isn’t Boston or SF
I live and work in Louisville, KY, a city that probably isn’t too different from a lot of communities in the U.S. that are not biotech hubs like San Francisco and Boston. Driven in part by economic...
Drugs and Medications
Ocufresh [Taiwan Biotech Co, Ltd]
Minidrops [Taiwan Biotech Co, Ltd]
Iman time control all day moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]
Drug Fact
Iman time control oil free moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]
Drug Fact
Stelara [Janssen Biotech, Inc.]
These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...
PubMed Articles
We investigated the effect of temperature on development and demographic parameters such as the intrinsic rate of natural increase (r (m)) of the two spider mite species Tetranychus merganser Boudreau...
Biotech 101: An Educational Outreach Program in Genetics and Biotechnology.
Recent advances in research and biotechnology are making genetics and genomics increasingly relevant to the lives and health of the general public. For the public to make informed healthcare and publi...
Goosanders (Mergus merganser, ad, adult n = 42: M, males 33 and F, females 9; im, immature n = 17: M 8, F 9) were collected in 2005 at wintering site in the River Odra estuary (Poland). The body size...
Industry progress report on neuro-oncology: a biotech update.
With steadily rising revenue and large numbers of clinical trials utilizing novel treatment strategies, the field of neuro-oncology is at the core of the growing cancer therapy industry. In June 2012,...
Clinical Trials
Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides
Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...
Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed Condition
The objective of the study is to compare the bioavailability and characterise the pharmacokinetic profile of Mycophenolate mofetil 250 mg capsules Panacea Biotech Ltd, India and Cellcept®...
Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream
Welichem Biotech has developed a small molecule drug candidate, WBI-1001, that selectively targets the pathogenic features of inflammatory skin diseases, including atopic dermatitis (a for...
Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fasting Condition
The objective of the study is to compare the bioavailability and characterise the pharmacokinetic profile of Mycophenolate mofetil 250 mg capsules Panacea Biotech Ltd, India and Cellcept®...
This is a randomized, controlled trial in liver transplantation in which conventional immunosuppressive treatment will be compared with a therapeutic strategy consisting in pre-transplant...
Companies
Merganser Biotech is a largely virtual, development only company focused on the licensing and development of early stage, novel peptidyl therapeutic approaches to the treatment...
The Biotech industry stimulates growth and creates new job opportunities in Sweden. The city of Umeå hosts first-rate biotech research. BioTech Umeå is a driving force helping the industry as well a...
Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...
M-Biotech was founded in 1997 and is located in Salt Lake City, Utah. M-Biotech's core business includes the research and development of biosensors for health care applications. Based on M-Biotech's p...
Cella Biotech is a company that is specialized in confirming and mapping protein-protein interactions using the yeast two-hybrid system. Companies and institutions can outsource some of their protein-...
More Information about "Merganser Biotech, Inc." on BioPortfolio
We have published hundreds of Merganser Biotech, Inc. news stories on BioPortfolio along with dozens of Merganser Biotech, Inc. Clinical Trials and PubMed Articles about Merganser Biotech, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Merganser Biotech, Inc. Companies in our database. You can also find out about relevant Merganser Biotech, Inc. Drugs and Medications on this site too.
